Latvia Tightens Tobacco Sales Regulations, Businesses Seek Loopholes to Evade

Dec.31.2024
Latvia Tightens Tobacco Sales Regulations, Businesses Seek Loopholes to Evade
Latvia tightens tobacco regulations, forcing companies to seek loopholes before new laws ban sales to under-20s in 2025.

According to a report by Euro News on December 31st, Latvia is planning to tighten regulations on the sale of tobacco products and their alternatives, forcing businesses in the country to seek legal loopholes to circumvent the new law.


Starting in January 2025, tobacco products (including disposable e-cigarettes, refillable e-cigarettes, and nicotine pouches) will be banned from being sold to individuals under the age of 20. The new regulations also mandate that e-cigarette products must be flavorless or only have a tobacco flavor, and the nicotine content in nicotine pouches will be restricted.


A survey by Latvijas Televīzija, the national television station of Latvia, has revealed that some companies selling pod supplements are trying to find ways to continue selling their products before new laws come into effect. For example, one company plans to sell individual nicotine and flavorings for customers to mix themselves.


The representative of the e-cigarette company Ecodumas, Jekaterina Smirnova, stated that


After the New Year, although we will offer alternatives to customers, the range will not be as extensive as before. We plan to gradually increase the variety of products and believe that after some time, the product range will definitely become larger.


Member of the Board of the Latvian Smoke-free Tobacco Products Association, Anrijs Matiss, stated,


I believe that relatives and friends can also bring these products from abroad. And just like all illegal items, trading through Telegram may also develop, which is difficult to prevent.


Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.

Japan Tobacco Q1 2025 Results: Revenue Up 11.7% to $5.8 Billion, Heated Tobacco Sales Rise 28%
Japan Tobacco Q1 2025 Results: Revenue Up 11.7% to $5.8 Billion, Heated Tobacco Sales Rise 28%
Japan Tobacco Inc. (JT) reported first-quarter revenue of ¥827 billion ($5.8 billion), up 11.7% year-on-year, driven by double-digit growth in reduced-risk products (RRP). The company announced plans to divest its pharmaceutical business, with the transaction expected to close in the second half of the year. Management reiterated its medium- to long-term strategic goal of achieving approximately 15% market share in key heated tobacco markets by the end of 2028.
May.07 by 2FIRSTS.ai
PMI Brazil CEO Urges Policy Rethink, Backs Smoke-Free Alternatives Like IQOS and Zyn
PMI Brazil CEO Urges Policy Rethink, Backs Smoke-Free Alternatives Like IQOS and Zyn
Branko Svarcic, CEO of Philip Morris Brazil, says the country should rethink its public health approach, especially on e-cigarettes and heated tobacco. While Brazil has banned e-cigarettes since 2009, products like IQOS and Zyn are seen as harm-reduction tools in many countries. He urged the government to learn from global examples and update its policies.
May.26 by 2FIRSTS.ai
PMI Sanctioned by DTI for Violating Philippine Regulations: IQOS ILUMA Limited Edition Advertising Halted
PMI Sanctioned by DTI for Violating Philippine Regulations: IQOS ILUMA Limited Edition Advertising Halted
On April 23, 2025, the Philippine Department of Trade and Industry (DTI) formally charged PMFTC, the Philippine affiliate of Philip Morris International, with violating RA11900, the Vaporized Nicotine and Non-Nicotine Products Regulation Act. The DTI ordered an immediate halt to all promotional activities related to the IQOS ILUMA x Steve Aoki limited edition product.
Apr.24 by 2FIRSTS.ai
From Glo Hyper Pro to Industry Realignment: A Defining Move by BAT’s Former Design Head——For Jonathon Lister, good design starts not with form or flair—but with trust, ethics, and regulatory clarity
From Glo Hyper Pro to Industry Realignment: A Defining Move by BAT’s Former Design Head——For Jonathon Lister, good design starts not with form or flair—but with trust, ethics, and regulatory clarity
In an exclusive interview with 2Firsts, former BAT Design Director Jonathon Lister offers an in-depth analysis of the design philosophy and strategic thinking behind glo Hyper Pro. He advocates for design that builds trust, responds to regulation, and conveys values—arguing that the future of novel tobacco products lies not in manufacturing capability, but in cultural judgment and ethical awareness. This is not just the story of a product, but an attempt to reshape the industry's way of thinking
Jun.11
FDA Appoints Bret Koplow as Acting Director of CTP
FDA Appoints Bret Koplow as Acting Director of CTP
According to the U.S. Food and Drug Administration’s website, Bret Koplow has been appointed acting director of the Center for Tobacco Products (CTP). Koplow has been with the FDA since 2011, holding several key roles, most recently serving as senior advisor to the FDA Commissioner.
May.21 by 2FIRSTS.ai
Philippine Tax Bureau Seizes $270,000 Worth of Illegal E-Cigarettes Sold Online at Cut-Rate Prices
Philippine Tax Bureau Seizes $270,000 Worth of Illegal E-Cigarettes Sold Online at Cut-Rate Prices
The Philippine Bureau of Internal Revenue (BIR) recently raided a residence in Tondo, Manila, seizing illegal e-cigarette products and accessories worth approximately PHP 15 million ($270,000).
May.27 by 2FIRSTS.ai